Zhejiang Wild Wind Pharmaceutical Co., Ltd. was founded in 1996 and belongs to Wild Wind Group with a registered capital of 75 million yuan. The company is located in Geshan Town Industrial Zone, Dongyang City, Zhejiang Province, next to Zhuyong Expressway.
The company's main business is the R&D, production and sales of specialty APIs and pharmaceutical intermediates. The products are based on dopa-based APIs, continuously enriching the product series, and expanding to fengin APIs and statin APIs, mainly including Featured APIs and intermediates such as methyldopa, levodopa, carbidopa, caspofungin acetate, etc. The main application areas are antihypertensive drugs, especially drugs for the treatment of pregnancy-induced hypertension and renal hypertension, and Anti-Parkinson medicine, Antifungal medicine, etc. At present, the main source of the company's revenue and profits is the Dopa series products. The Fungin series and statin series products are gradually increasing and expanding. The rich product echelon is an important cornerstone of the company's future development; technically, the company's R&D team Continuously improve the traditional chemical synthesis production process, and vigorously develop the biological fermentation process, and organically combine the two to consolidate the technical advantage of the combination of "chemical synthesis + biological fermentation". Our factory obtain a number of API certification qualifications relying on the excellent product quality and the ability of drug regulatory registration in different countries and markets , and continues to open new markets.